Trends in mammalian cell cultures

Technology Market Penetration and Roadmapping

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

With the growing need for better therapeutics, and the current patent cliff that is underway, therapies such as monoclonal antibodies, recombinant protein therapeutics and even vaccines for a whole host of indications are in high demand. Conventionally expression systems were utilized to aid in the development and production of these therapeutics. However, due to issues with low yields, poor quality and high costs, novel approaches and novel expression systems are currently being discovered.

Mammalian expression systems are the most rapidly growing segment across all expression systems, and their utility has now been advanced with the capability to integrate more technologies together such as genome editing technologies and genetic manipulation technologies. Mammalian expression systems are mostly developed using Chinese Hamster Ovary (CHO) cells and HEK-293 (Human Embryonic Kidney) cells. There have been no significant changes with respect to the cell-types used. Developments have been incremental, with emphasis on production efficiency, yield, DNA vectors used for cell transfection, and the breadth of recombinant products derived from the expression system.

This research service brings out the emerging trends in mammalian cell culture systems on a global scale, through a detailed description of:
The technology capability and value chain; analysis of global technology trends.
An impact analysis of major drivers, restraints, and challenges influencing the growth of cell banks by timeframes.
An assessment of technology adoption and development, by region, demand side analysis, and recommendations for technology/product/services developers.
An evaluation of scenario modelling and emerging opportunities in mammalian cell culture systems , technology management strategies and technology application roadmap.
A list of key patents of noteworthy innovations of global participants and a detailed list of key contacts in the field.

Table of Contents

Executive SummaryResearch ScopeKey Findings Research MethodologyTechnology Snapshot and TrendsTechnology Overview Technology Process Overview Industrial Application Areas Technology Value ChainImpact Assessment and AnalysisMarket Impact of Key Innovations Market Impact of Key Innovations Market Impact of Key Innovations Market Impact of Key Innovations Market Impact of Key Innovations Market Impact of Key Innovations Market Impact of Key Innovations Market Impact of Key Innovations Market Impact of Key Innovations Market Impact of Technology Market Impact of Technology Market Impact of Technology Market Impact of Technology Diffusion of Innovations and Needs AssessmentTechnology Adoption CycleTechnology Adoption Cycle Technology Adoption CycleTechnology Adoption CycleTechnology Adoption CycleTechnology Adoption CycleTechnology Adoption CycleOpportunity Evaluation and RoadmappingDemand Side AnalysisPercent projection of cell culture and cell line development activities outsourced to CMOs (2012-2018)Source: Frost & SullivanSource: Frost & SullivanKey Contacts & PatentsContactsPatentsPatents (continued)Legal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.